Besides EGFR mutations, a part of NSCLC is classified as oncogene-addicted NSCLC, which harbors driver mutations, including ALK, ROS1, BRAF, MET, HER2, RET, K-RAS, or NTRK mutations [32,33]. Here, MET is linked to non-small cell lung carcinoma.